robatumumab: Clinical Trials

3 trials of robatumumab, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated, 1 completed. 3 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Terminated 2, Completed 1
Phase 11Terminated 1

Follow robatumumab: new trials by email Literature Review of robatumumab trials Research Report on robatumumab

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Participants With Advanced Solid Tumors (P04722, MK-7454-004)
Carboplatin, Epirubicin, Trastuzumab - Neoplasms
Phase 1 / Phase 2TerminatedMerck Sharp & Dohme LLC152009-09-252018-08-24
A Study to Determine the Activity of Robatumumab (SCH 717454) in Participants With Relapsed Osteosarcoma or Ewing's Sarcoma (MK-7454-002/P04720)
robatumumab - Osteosarcoma, Sarcoma, Ewing's
Phase 2TerminatedMerck Sharp & Dohme LLC2192008-02-012018-08-23
A Study to Determine the Activity of Robatumumab (SCH 717454, MK-7454) in Participants With Relapsed or Recurrent Colorectal Cancer (P04721, MK-7454-003)
Robatumumab, Irinotecan, Cetuximab - Colorectal Cancer
Phase 2CompletedMerck Sharp & Dohme LLC672007-11-212018-08-24

Conditions studied

Colorectal Neoplasms (1)  ·  Neoplasms (1)  ·  Neuroectodermal Tumors, Primitive, Peripheral (1)  ·  Osteosarcoma (1)  ·  Sarcoma, Ewing (1)

Sponsors

Merck Sharp & Dohme LLC (3)

Results publications

PMID 22682017, PMID 24905030, PMID 27362300

NIH funding

2009 (1)